1. Tianjin 3D Imaging Technique Co., Ltd. (TJ3D)

Founded in 1993, TJ3D is a joint venture engaging in new and high technology businesses including R&D in 3D imaging as well as the production and sales of relevant products such as 3D TV and cinema systems, 3D computer graphics, 3D displays & projectors and 3D eyeglasses. Having more than 40 hardware and software engineers, they boast more than 40 fruitful projects and have been granted over 20 patents both at home and abroad. And with the most extensive worldwide coverage of 3D TV broadcasting network airing 3D programs produced by TJ3D, actually it is regarded as one of the world leaders in 3D imaging.

2. Tianjin TEDA Bio-medical Engineering Co., Limited (TEDA Bio-medical)

TEDA Bio-medical is established in 2000 and went public on the Growth Enterprise Market of Stock Exchange of Hong Kong in 2002. It is specialized in producing quality medical and health products including medical devices, natural medicines and health care food. In building a leading brand in bio-medical engineering, it focuses on technological innovation and improvement, and has been engaged actively in new product development via cooperation with key universities, research institutes and groups. Products already in production include Sodium Hyaluronate, medical monitoring devices, medical catheters and health care food for diabetics. They are currently working on the R&D of Curcumin and artificial lens.

3. BOYI(Tianjin) Pneumatic Technology Institute Co., Ltd.

As the very first incubated company started by a returned oversea Chinese student in TII in 1997, BOYI had gone through many difficulties in its early period and also been hit by the 1998 Asian financial crisis. It has then developed rapidly after three years’ incubation in the TII and become the first graduated enterprise run by returned oversea Chinese students. The air pressure testing and control technology developed independently by BOYI is leading the way in the world and has filled up the vacancy in this field in China. A new plant had been put into production in 2006 and the expected total output in 2006 would amount to RMB 60 million.

4. Tianjin Wincosoft (Gold Abacus) Software Co., Ltd.

Tianjin Gold Abacus belongs to China’s third largest and the fastest-growing management software corporation – the Gold Abacus is headquartered in Chongqing. The corporation now has more than 28 branches in China and over 1200 employees. With advanced thinking on administration and proactive philosophy on operation, Gold Abacus offers quality management software and customized solutions to clients in various industries and provides them with professional consulting, training and technological services. Gold Abacus has been well-known for creative and quality products since its launching of China’s first Windows-based finance software in 1994 and its client-centered services. Other widely-used products include: Gold Abacus Valuable Platform, and GASOFT Value Platform Suites.

5. National Peiyang Distillation Technology Engineering Limited Company (Peiyang Distillation or PYD)

PYD is a joint venture between Tianjin University (f/k/a Peiyang University) and the TII, with a total registered capital of RMB 55.68 million. With the backing of National Engineering Research Center of Distillation Technology (NERCDT), PYD focuses on the development of new distillation process, equipment and refining technologies to realize industrialization. Utilizing a total investment of RMB 60 million into the construction of its pre-production test and industrial bases, it now has sufficient equipment to allow economies of scale to be achieved, with a total output value of RMB 0.1 billion. PYD also boasts 14 patents, a highly educated workforce, advanced simulation software, and a strict quality control system.

6. Tianjin SinoBio-tech Ltd.

Founded in TII in 2004 with its technologies and managerial talents originated from Fortune Rock, Inc., USA, SinoBio-tech is specialized in product development and technical platform of gene therapy, aiming at innovation and R&D of gene-based drugs. By taking advantages of its highly experienced and educated workforce, independent IPRs and advanced technologies and equipment, SinoBiotech is engaged in gene product development and industrialization with reference to current situations of China’s pharmaceutical and bio-technological industry. It has established extensive cooperation with domestic or overseas institutions such as pharmaceutical businesses, hospitals, institutional investors, governments and universities, striving to create its own high-tech products in the short run.

7. Tianjin Nanda-Qiangxin IC Design Co., Ltd. (Nanda-Qiangxin)

Nanda-Qiangxin is established in 2002 by three returned overseas Chinese talents from Japan. It is a specialized high-tech enterprise engaging in the design and development of LSI circuits. Having strong connection with Nankai University, Nanda-Qiangxin has received massive support from the government since its establishment and has succeeded in completing many advanced projects of high-grade and precision. The company also assumes the mission of training and provision of professionals in microelectronic and IC design for Tianjin and China. It is well-known for its honor-winning 90nm CMOS SOC project of 2003, and it was approved and listed as one of the national post-doctoral research stations in 2006.

8. Tianjin Union Biotechnology Development Co., Ltd. (TUBD) or Institute of Tianjin Union Biotechnology Development (ITUBD)

TUBD is a technology-based private enterprise established through sino-foreign cooperation. Its primary businesses are bio-technology, bio-pharmaceuticals, and the modernization of traditional Chinese medicine; it is also diversifying into health care products and diagnostic reagents concerning subhealth symptoms. TUBD is proud of its experienced executives and international professionals with expertise in bio-technology, pharmaceutical engineering, bio-chemistry, transfusion and hematology, and clinical medicine. Four of its bio-pharmaceuticals have passed the laboratory stage and are now under preclinical pre-production tests, with bright prospects on the US market. They are now working on the R&D of Hydroxyethyl starch (HES) and diagnostic reagent for rapid detection of HIV antibodies.

9. Tianjin Bonna-Agela Technologies Inc.

Bonna-Agela is a joint venture established in 2007 manufacturing new material products (via chromatographic resolution) for bio-pharmaceuticals, food safety and inspection, and environmental monitoring. Its core technologies include the design, preparation and application of new separation technologies and materials, surface modification of porous materials, and the use of Nano-materials in biochemical separation and detection. Bonna-Agela has developed its own consumable materials which have realized partial commercialization. Its surface treatment technique for silica gel has taken the lead in the industry with superior competitive advantage on the domestic market. To retain high level R&D capabilities, the company has formed intense partnership with other institutions, ensuring constant personnel and technological communications.